Source: Annual Congress 2011 - The ageing pulmonary interstitium
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Martin, A. P. Velosa, A. Santos, S. Carrasco, A. Santos, E. Parra, C. Goldenstein-Schainberg, N. Yoshinari, V. Capelozzi, T. Walcy (São Paulo, Brazil). Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis. Eur Respir J 2011; 38: Suppl. 55, 790

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015 Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Interstitial lung diseases in collagen vascular diseases Source: Eur Respir J 2001; 18: 69S-80S Year: 2001 Lysyl oxidases in idiopathic pulmonary fibrosis: A key participant in collagen I matrix remodelling Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Up-regulation of collagen type V mRNA in a model of systemic sclerosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Arterial type V collagen disorganization in patients with systemic sclerosis: preliminary study Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Type V collagen induced pulmonary fibrosis in C57Bl/6mice Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Auto-antibody subsets and extent of pulmonary fibrosis in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 202s Year: 2005 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Metabolic shift during TGF- β-induced collagen synthesis Source: International Congress 2016 – IPF pathogenesis Year: 2016 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010